Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy T

• click to rate

  Posted by Two Blokes Jun 13 - Filed in Stock - 8 views
  
  RCKT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , June 13, 2025 /PRNewswire/ -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al.